We report here that RITA shows anti-tumor activity in vitro against medulloblastoma cell lines independent of TP53 status as well as in vivo against a xenograft tumor formed using a medulloblastoma cell line lacking TP53 mutation. The gene discussed is TP53; the disease is medulloblastoma.